Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

Brain Structural Effects of Antipsychotic Treatment in Schizophrenia: A Systematic Review.

Roiz-Santia├▒ez R, Suarez-Pinilla P, Crespo-Facorro B.

Curr Neuropharmacol. 2015;13(4):422-34. Review.

2.

Positive allosteric modulators of metabotropic glutamate 2 receptors in schizophrenia treatment.

Ellaithy A, Younkin J, González-Maeso J, Logothetis DE.

Trends Neurosci. 2015 Aug;38(8):506-16. doi: 10.1016/j.tins.2015.06.002. Epub 2015 Jul 4. Review.

3.

Brain imaging during the transition from psychosis prodrome to schizophrenia.

Chung Y, Cannon TD.

J Nerv Ment Dis. 2015 May;203(5):336-41. doi: 10.1097/NMD.0000000000000286. Review.

4.

Progressive Brain Atrophy and Cortical Thinning in Schizophrenia after Commencing Clozapine Treatment.

Ahmed M, Cannon DM, Scanlon C, Holleran L, Schmidt H, McFarland J, Langan C, McCarthy P, Barker GJ, Hallahan B, McDonald C.

Neuropsychopharmacology. 2015 Sep;40(10):2409-17. doi: 10.1038/npp.2015.90. Epub 2015 Apr 1.

5.

Influence of early trauma on features of schizophrenia.

Ruby E, Rothman K, Corcoran C, Goetz RR, Malaspina D.

Early Interv Psychiatry. 2015 Mar 23. doi: 10.1111/eip.12239. [Epub ahead of print]

6.

Pathways Associating Childhood Trauma to the Neurobiology of Schizophrenia.

Ruby E, Polito S, McMahon K, Gorovitz M, Corcoran C, Malaspina D.

Front Psychol Behav Sci. 2014 Jan 1;3(1):1-17.

7.

Divergent effects of first-generation and second-generation antipsychotics on cortical thickness in first-episode psychosis.

Ansell BR, Dwyer DB, Wood SJ, Bora E, Brewer WJ, Proffitt TM, Velakoulis D, McGorry PD, Pantelis C.

Psychol Med. 2015 Feb;45(3):515-27. doi: 10.1017/S0033291714001652. Epub 2014 Jul 31.

8.

Progressive reduction of visual P300 amplitude in patients with first-episode schizophrenia: an ERP study.

Oribe N, Hirano Y, Kanba S, Del Re E, Seidman L, Mesholam-Gately R, Goldstein JM, Shenton M, Spencer KM, McCarley RW, Niznikiewicz M.

Schizophr Bull. 2015 Mar;41(2):460-70. doi: 10.1093/schbul/sbu083. Epub 2014 Jun 9.

9.

Magnetic resonance imaging in studying schizophrenia, negative symptoms, and the glutamate system.

Gruber O, Chadha Santuccione A, Aach H.

Front Psychiatry. 2014 Apr 3;5:32. doi: 10.3389/fpsyt.2014.00032. eCollection 2014. Review.

10.

Childhood onset schizophrenia and early onset schizophrenia spectrum disorders.

Driver DI, Gogtay N, Rapoport JL.

Child Adolesc Psychiatr Clin N Am. 2013 Oct;22(4):539-55. doi: 10.1016/j.chc.2013.04.001. Epub 2013 Jun 18.

11.

Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies.

Fusar-Poli P, Smieskova R, Kempton MJ, Ho BC, Andreasen NC, Borgwardt S.

Neurosci Biobehav Rev. 2013 Sep;37(8):1680-91. doi: 10.1016/j.neubiorev.2013.06.001. Epub 2013 Jun 14.

12.

Relapse duration, treatment intensity, and brain tissue loss in schizophrenia: a prospective longitudinal MRI study.

Andreasen NC, Liu D, Ziebell S, Vora A, Ho BC.

Am J Psychiatry. 2013 Jun;170(6):609-15. doi: 10.1176/appi.ajp.2013.12050674. Erratum in: Am J Psychiatry. 2013 Jun 1;170(6):689.

13.

Effects of davunetide on N-acetylaspartate and choline in dorsolateral prefrontal cortex in patients with schizophrenia.

Jarskog LF, Dong Z, Kangarlu A, Colibazzi T, Girgis RR, Kegeles LS, Barch DM, Buchanan RW, Csernansky JG, Goff DC, Harms MP, Javitt DC, Keefe RS, McEvoy JP, McMahon RP, Marder SR, Peterson BS, Lieberman JA.

Neuropsychopharmacology. 2013 Jun;38(7):1245-52. doi: 10.1038/npp.2013.23. Epub 2013 Jan 16.

14.

Localized differences in caudate and hippocampal shape are associated with schizophrenia but not antipsychotic type.

McClure RK, Styner M, Maltbie E, Lieberman JA, Gouttard S, Gerig G, Shi X, Zhu H.

Psychiatry Res. 2013 Jan 30;211(1):1-10. doi: 10.1016/j.pscychresns.2012.07.001. Epub 2012 Nov 9.

15.

Hospitalization and psychosis: influences on the course of cognition and everyday functioning in people with schizophrenia.

Harvey PD, Loewenstein DA, Czaja SJ.

Neurobiol Dis. 2013 May;53:18-25. doi: 10.1016/j.nbd.2012.10.022. Epub 2012 Oct 31. Review.

16.

Cannabis abuse and brain morphology in schizophrenia: a review of the available evidence.

Malchow B, Hasan A, Fusar-Poli P, Schmitt A, Falkai P, Wobrock T.

Eur Arch Psychiatry Clin Neurosci. 2013 Feb;263(1):3-13. doi: 10.1007/s00406-012-0346-3. Epub 2012 Aug 21. Review.

17.

Visual information processing dysfunction across the developmental course of early psychosis.

Perez VB, Shafer KM, Cadenhead KS.

Psychol Med. 2012 Oct;42(10):2167-79. doi: 10.1017/S0033291712000426. Epub 2012 Apr 3.

18.

The structural neural substrates of persistent negative symptoms in first-episode of non-affective psychosis: a voxel-based morphometry study.

Benoit A, Bodnar M, Malla AK, Joober R, Lepage M.

Front Psychiatry. 2012 May 8;3:42. doi: 10.3389/fpsyt.2012.00042. eCollection 2012.

19.

Intact relational memory and normal hippocampal structure in the early stage of psychosis.

Williams LE, Avery SN, Woolard AA, Heckers S.

Biol Psychiatry. 2012 Jan 15;71(2):105-13. doi: 10.1016/j.biopsych.2011.09.016. Epub 2011 Nov 4.

20.

Role of CpG context and content in evolutionary signatures of brain DNA methylation.

Xin Y, O'Donnell AH, Ge Y, Chanrion B, Milekic M, Rosoklija G, Stankov A, Arango V, Dwork AJ, Gingrich JA, Haghighi FG.

Epigenetics. 2011 Nov;6(11):1308-18. doi: 10.4161/epi.6.11.17876. Epub 2011 Nov 1.

Items per page

Supplemental Content

Write to the Help Desk